ATE397662T1 - Neues polypeptid, dafür kodierende dna und deren verwendungen - Google Patents
Neues polypeptid, dafür kodierende dna und deren verwendungenInfo
- Publication number
- ATE397662T1 ATE397662T1 AT98905674T AT98905674T ATE397662T1 AT E397662 T1 ATE397662 T1 AT E397662T1 AT 98905674 T AT98905674 T AT 98905674T AT 98905674 T AT98905674 T AT 98905674T AT E397662 T1 ATE397662 T1 AT E397662T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptide
- dna coding
- new polypeptide
- antibody
- dna
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000002536 stromal cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4314397 | 1997-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE397662T1 true ATE397662T1 (de) | 2008-06-15 |
Family
ID=12655623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98905674T ATE397662T1 (de) | 1997-02-27 | 1998-02-26 | Neues polypeptid, dafür kodierende dna und deren verwendungen |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US7396908B2 (de) |
| EP (1) | EP0990703B1 (de) |
| KR (1) | KR20000075749A (de) |
| AT (1) | ATE397662T1 (de) |
| DE (1) | DE69839582D1 (de) |
| DK (1) | DK0990703T3 (de) |
| ES (1) | ES2307313T3 (de) |
| PT (1) | PT990703E (de) |
| WO (1) | WO1998038304A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9376498A (en) * | 1997-09-05 | 1999-03-22 | University Of Washington | Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents |
| ES2286856T3 (es) | 1997-09-12 | 2007-12-01 | Biogen Idec Ma Inc. | Receptores train ricos en cisteina. |
| IL136988A0 (en) * | 1997-12-29 | 2001-06-14 | Regeneron Pharma | Novel nucleic acid and polypeptide |
| EP1053351A4 (de) * | 1998-01-27 | 2002-09-25 | Millennium Pharm Inc | Neue moleküle der tnf-rezeptorsuperfamilie und verwendungen dafür |
| WO2000049149A1 (fr) * | 1999-02-19 | 2000-08-24 | Toshio Kitamura | Nouvelles proteines du type recepteurs des tnf |
| CA2381327A1 (en) * | 1999-07-16 | 2001-01-25 | Steven M. Ruben | Human tumor necrosis factor receptors tr13 and tr14 |
| US6951738B2 (en) | 1999-07-16 | 2005-10-04 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptors TR13 and TR14 |
| EP1254176B1 (de) * | 2000-02-11 | 2008-01-09 | Genetics Institute, LLC | Verwendung der extrazellulären Domäne von TRADE Molekülen in Medikamenten zur Behandlung von Neoplasie |
| BR0207297A (pt) | 2001-02-15 | 2005-04-19 | King Pharmaceuticals Inc | Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| EP1789070B1 (de) | 2004-08-03 | 2012-10-24 | Biogen Idec MA Inc. | Taj in der neuronalen funktion |
| HK1207095A1 (en) | 2012-07-18 | 2016-01-22 | 阿珀吉尼科斯股份公司 | Composition comprising a mixture of cd95-fc isoforms |
| KR102209958B1 (ko) † | 2012-10-24 | 2021-02-01 | 바스프 에스이 | 액상으로의 아민의 포스겐화에 의한 이소시아네이트의 제조 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9214857D0 (en) | 1992-07-13 | 1992-08-26 | Medical Res Council | Human nucleic acid fragments and their use |
| ES2286856T3 (es) * | 1997-09-12 | 2007-12-01 | Biogen Idec Ma Inc. | Receptores train ricos en cisteina. |
-
1998
- 1998-02-26 AT AT98905674T patent/ATE397662T1/de not_active IP Right Cessation
- 1998-02-26 ES ES98905674T patent/ES2307313T3/es not_active Expired - Lifetime
- 1998-02-26 EP EP98905674A patent/EP0990703B1/de not_active Expired - Lifetime
- 1998-02-26 PT PT98905674T patent/PT990703E/pt unknown
- 1998-02-26 DK DK98905674T patent/DK0990703T3/da active
- 1998-02-26 DE DE69839582T patent/DE69839582D1/de not_active Expired - Lifetime
- 1998-02-26 WO PCT/JP1998/000799 patent/WO1998038304A1/ja not_active Ceased
- 1998-02-26 KR KR1019997007819A patent/KR20000075749A/ko not_active Ceased
-
2004
- 2004-02-10 US US10/774,378 patent/US7396908B2/en not_active Expired - Fee Related
-
2007
- 2007-11-05 US US11/935,305 patent/US7705140B2/en not_active Expired - Fee Related
-
2010
- 2010-02-01 US US12/697,676 patent/US8008451B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT990703E (pt) | 2008-08-27 |
| EP0990703A1 (de) | 2000-04-05 |
| KR20000075749A (ko) | 2000-12-26 |
| EP0990703B1 (de) | 2008-06-04 |
| US20040142423A1 (en) | 2004-07-22 |
| ES2307313T3 (es) | 2008-11-16 |
| US8008451B2 (en) | 2011-08-30 |
| US20080175843A1 (en) | 2008-07-24 |
| WO1998038304A1 (en) | 1998-09-03 |
| US7396908B2 (en) | 2008-07-08 |
| US7705140B2 (en) | 2010-04-27 |
| DE69839582D1 (de) | 2008-07-17 |
| US20100298546A1 (en) | 2010-11-25 |
| DK0990703T3 (da) | 2008-09-29 |
| EP0990703A4 (de) | 2001-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE444361T1 (de) | Il-17 und il-17r homologe polypeptide und deren therapeutische verwendungen | |
| ATE397662T1 (de) | Neues polypeptid, dafür kodierende dna und deren verwendungen | |
| HU9600692D0 (en) | Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds | |
| EP0994728A4 (de) | Für die termini des beta-amyloids spezifische, rekombinante antikörper, dafür kodierende dna und verfahren zu ihrer verwendung | |
| ES2193145T3 (es) | Proteinas procoagulants quimericas. | |
| IL143670A0 (en) | Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same | |
| HUP0103758A2 (hu) | Neurotróf faktorok | |
| ATE394484T1 (de) | Smad 6 und dessen anwendungen | |
| DE69433690D1 (de) | Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür | |
| IL85878A0 (en) | Anticoagulant proteins,dna coding for them,processes for preparing them,pharmaceutical compositions containing them,monoclonal antibodies against such proteins and hybrid cell lines which secrete these antibodies | |
| ATE242323T1 (de) | Transportprotein, das den transport von kationischen xenobiotika und/oder pharmaka bewirkt, dafür kodierende dna-sequenzen und deren verwendung | |
| EE200000151A (et) | Aminoterminaalselt kärbitud rantes vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon | |
| DK0817851T3 (da) | DNA, der koder for humant papillomvirus type 18 | |
| BR0312889A (pt) | Polipeptìdeo t20 peguilado | |
| ATE385517T1 (de) | Interferon ähnliche moleküle, und deren verwendungen | |
| DE69328060D1 (de) | Angiotensin-II Typ-1 Rezeptor und dessen Herstellung | |
| WO1996009391A3 (en) | Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19 | |
| NO980122D0 (no) | Emaljematriksrelatert polypeptid | |
| DE3853693D1 (de) | DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung. | |
| EP0676413A3 (de) | Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung. | |
| DE69941099D1 (de) | Spezifische Nukleinsäuren und Polypeptide aus krankheitserregenden Stämmen von Neisseria | |
| ATE111920T1 (de) | Lymphokine, dns-sequenzen, die diese lymphokine kodieren, und sie enthaltende pharmazeutische zusammensetzungen. | |
| EP1019500A4 (de) | Neue ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone | |
| FR2859221B1 (fr) | Vecteur de co-expression de domaines membranaires de proteines d'enveloppe d'un virus et utilisations | |
| UA35624C2 (uk) | МОЛЕКУЛА ДНК, ЩО КОДУЄ ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, ВЕКТОР, L-КЛІТИНА, ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, СПОСІБ ЙОГО ОТРИМАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, МОНОКЛОНАЛЬНЕ АНТИТІЛО |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0990703 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |